Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis. The gene discussed is CMIP; the disease is metabolic dysfunction-associated steatotic liver disease.